Weber Jeffrey, Hauschild James, Ijzerman-Boon Pieta, Forng Ren-Yo, Horsch Jeff, Yan Lisa, Prasad Aditya, Henry Robert Bo, Claassen Marja, Villari Philip, Shereefa Shebeer, Wyatt Jane, Bolden Jay S, Pycke Jean-Thierry, Dassu Dawood
Pfizer, Kalamazoo, MI, USA.
Johnson & Johnson, East Raritan, NJ, USA.
PDA J Pharm Sci Technol. 2019 Mar-Apr;73(2):121-134. doi: 10.5731/pdajpst.2018.008722. Epub 2018 Oct 25.
This paper provides recommendations for quality oversight, manufacturing operations, and industry perspective of regulatory expectations to enable aseptic facilities to move toward real-time and continuous microbiological environmental monitoring, thereby reducing interventions and future replacement of Grade A settle plates and nonremote active air sampling. The replacement of traditional monitoring with biofluorescent particle-counting systems provides an improvement in process understanding and product safety and reduces operator manipulations, assuring product quality and real-time process verification. The future state pharmaceutical technology roadmaps include gloveless isolators with real-time and continuous monitoring for aseptic manufacturing. This paper advocates the use of an alternative and relatively new method of monitoring the air for contamination in biopharmaceutical manufacturing facilities. The alternative method is based on a type of instrument the authors refer to as a biofluorescent particle counter (BFPC). The BFPC method has the advantage of being able to detect airborne microorganisms continuously and to record the actual time of detection. The replacement of traditional monitoring with BFPC systems can provide better data, which can be used to improve the understanding of contamination risks in complex manufacturing processes, ultimately providing more confidence in product safety. The authors present data showing the suitability of BFPC. This immediate result is very useful for picking up early any possible contamination and should, therefore, provide a better way to monitor and control the risk of contamination. As traditional monitoring methods require manual manipulation, an additional advantage of BFPC systems is that they can reduce manual manipulations. Elimination of all interventions is a goal in the industry, because although they are tightly controlled, interventions are an unwanted potential source of contamination.
本文针对无菌设施向实时和连续微生物环境监测迈进的质量监督、生产操作及监管期望的行业视角提供了建议,从而减少A级沉降碟和非远程主动空气采样的干预及未来更换。用生物荧光颗粒计数系统取代传统监测可提升对工艺的理解及产品安全性,并减少操作人员的操作,确保产品质量和实时工艺验证。未来的制药技术路线图包括用于无菌生产的带实时和连续监测的无手套隔离器。本文提倡采用一种替代的且相对较新的方法来监测生物制药生产设施中的空气污染。该替代方法基于作者所称的生物荧光颗粒计数器(BFPC)这种仪器类型。BFPC方法的优势在于能够连续检测空气中的微生物并记录实际检测时间。用BFPC系统取代传统监测可提供更好的数据,用于增进对复杂生产过程中污染风险的理解,最终增强对产品安全性的信心。作者展示了表明BFPC适用性的数据。这一即时结果对于尽早发现任何可能的污染非常有用,因此应能提供一种更好的方式来监测和控制污染风险。由于传统监测方法需要人工操作,BFPC系统的另一个优势是它们可减少人工操作。消除所有干预是该行业的一个目标,因为尽管干预受到严格控制,但它们仍是不必要的潜在污染源。